Cormorant Asset Management, LP
Position in TARS — Tarsus Pharmaceuticals, Inc.
CIK 1583977
BOSTON, MA
Position in TARS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,294,000
-$9,489,750 QoQ
Shares Held
100,000
-55.6% QoQ
Ownership
0.228%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#56
of 256 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TARS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cormorant Asset Management, LP holds $1,889,506,429 across 46 Biotechnology names. TARS ranks #35 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
640,000 | $214,265,600 | |
| 2 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
17,878,594 | $136,234,886 | |
| 3 | PBLS |
Parabilis Medicines, Inc.
|
4,615,612 | $126,329,300 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
2,657,521 | $110,738,900 | |
| 5 | ERAS |
Erasca, Inc.
|
6,000,000 | $109,920,000 | |
| 6 | EWTX |
Edgewise Therapeutics, Inc.
|
2,510,000 | $101,981,300 | |
| 7 | EYPT |
EyePoint, Inc.
|
7,000,000 | $100,100,000 | |
| 8 | ALMS |
Alumis Inc.
|
3,285,596 | $92,456,671 |
All Filings in TARS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,294,000 | 100,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $15,783,750 | 225,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $20,470,000 | 250,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $17,829,000 | 300,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $12,153,000 | 300,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $20,548,000 | 400,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $27,685,000 | 500,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $16,445,000 | 500,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,590,000 | 500,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $77,756,357 | 2,139,102 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $44,983,795 | 2,221,422 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $46,582,668 | 2,621,422 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $25,685,095 | 1,421,422 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $17,867,274 | 1,421,422 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $25,455,946 | 1,736,422 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $33,750,744 | 1,971,422 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $27,375,000 | 1,875,000 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $23,144,017 | 1,375,982 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $31,574,947 | 1,403,331 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $31,136,108 | 1,444,831 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $43,883,515 | 1,514,269 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $55,250,889 | 1,714,269 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $70,850,737 | 1,714,269 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||